Katsiki, Niki

Non-alcoholic fatty liver disease and dyslipidemia: An update

Katsiki, N., Mikhailidis, D. P., & Mantzoros, C. S. (2016) · Metabolism

Liver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 564

Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel

Cicero, A. F. G., Colletti, A., Bajraktari, G., Descamps, O., Djuric, D. M., Ezhov, M., Fras, Z., Katsiki, N., Langlois, M., Latkovskis, G., et al. (2017) · Archives of Medical Science

Lipoproteins and Cardiovascular HealthNatural Products and Biological Research

Cited by 281

The Role of Nutraceuticals in Statin Intolerant Patients

Banach, M., Patti, A. M., Giglio, R. V., Cicero, A. F. G., Atanasov, A. G., Bajraktari, G., Bruckert, E., Descamps, O., Djuric, D. M., Ezhov, M., et al. (2018) · Journal of the American College of Cardiology

Lipoproteins and Cardiovascular HealthNatural Products and Biological Research

Cited by 272

Mediterranean Diet and Obesity-related Disorders: What is the Evidence?

Muscogiuri, G., Verde, L., Sulu, C., Katsiki, N., Hassapidou, M., Frias-Toral, E., Cucalón, G., Pazderska, A., Yumuk, V. D., Colao, A., et al. (2022) · Current Obesity Reports

Nutritional Studies and DietDiet and metabolism studies

Cited by 207

Semaglutide as a promising antiobesity drug

Christou, G. A., Katsiki, N., Blundell, J., Fruhbeck, G., & Kiortsis, D. N. (2019) · Obesity Reviews

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 159

Regulation of PCSK9 by nutraceuticals

Momtazi, A. A., Banach, M., Pirro, M., Katsiki, N., & Sahebkar, A. (2017) · Pharmacological Research

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 131

The role of fibrate treatment in dyslipidemia: an overview

Katsiki, N., Nikolic, D., Montalto, G., Banach, M., Mikhailidis, D. P., & Rizzo, M. (2013) · Current Pharmaceutical Design

Lipoproteins and Cardiovascular HealthPeroxisome Proliferator-Activated Receptors

Cited by 131

Anti-inflammatory properties of antidiabetic drugs: a “promised land” in the COVID-19 era?

Katsiki, N., & Ferrannini, E. (2020) · Journal of Diabetes and its Complications

Diabetes Treatment and ManagementCOVID-19 Clinical Research Studies

Cited by 91

Gut microbiota and aging-A focus on centenarians

Cӑtoi, A. F., Corina, A., Katsiki, N., Vodnar, D. C., Andreicuț, A. D., Stoian, A. P., Rizzo, M., & Pérez-Martínez, P. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Gut microbiota and healthProbiotics and Fermented Foods

Cited by 70

Postprandial hypertriglyceridaemia revisited in the era of non-fasting lipid profile testing: a 2019 Expert Panel Statement, Main Text

Kolovou, G. D., Watts, G. F., Mikhailidis, D. P., Pérez-Martínez, P., Mora, S., Bilianou, H., Panotopoulos, G., Katsiki, N., Ooi, T. C., Lopez-Miranda, J., et al. (2019) · Current Vascular Pharmacology

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 61

Volanesorsen: A New Era in the Treatment of Severe Hypertriglyceridemia

Kolovou, G., Kolovou, V., & Katsiki, N. (2022) · Journal of Clinical Medicine

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 33

The Impact of Smoking on Cardiovascular Outcomes and Comorbidities in Statin-treated Patients with Coronary Artery Disease: A Post hoc Analysis of the GREACE Study

Athyros, V. G., Tziomalos, K., Katsiki, N., Gossios, T. D., Giouleme, O., Anagnostis, P., Pagourelias, E. D., Theocharidou, E., Karagiannis, A., Mikhailidis, D. P., et al. (2013) · Current Vascular Pharmacology

Lipoproteins and Cardiovascular HealthSmoking Behavior and Cessation

Cited by 26

Primary aldosteronism in patients with adrenal incidentaloma: is screening appropriate for everyone?

Stavropoulos, K., Imprialos, K. P., Katsiki, N., Petidis, K., Kamparoudis, A., Petras, P., Georgopoulou, V., Finitsis, S., Papadopoulos, C., Athyros, V. G., et al. (2018) · The Journal of Clinical Hypertension

Hormonal Regulation and HypertensionAdrenal and Paraganglionic Tumors

Cited by 23

Drugs that Mimic the Effect of Gene Mutations for the Prevention or the Treatment of Atherosclerotic Disease: From PCSK9 Inhibition to ANGPTL3 Inactivation

Athyros, V. G., Katsiki, N., Dimakopoulou, A., Patoulias, D., Alataki, S., & Doumas, M. (2019) · Current Pharmaceutical Design

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 12